Table 1.
Baseline Patient Demographic and Clinical Characteristics (n = 46)
| Characteristic | n (%) |
|---|---|
| Age, years | |
| Median (range) | 69.5 (53, 87) |
| Ethnicity | |
| Hispanic or Latino | 1 (2) |
| Caucasian | 45 (98) |
| ECOG | |
| 0 | 30 (65) |
| 1 | 14 (31) |
| 2 | 2 (4) |
| Gleason score at diagnosis | |
| ≤ 7 | 22 (48) |
| 8 | 7 (15) |
| 9 | 14 (30) |
| 10 | 3 (7) |
| Extent of Disease | |
| Local recurrence | 2 |
| Bone only | 17 |
| Lymph node only | 5 |
| Bone and lymph node only | 14 |
| Non-metastatic biochemical relapse | 2 |
| Visceral involvement* | 8 |
| Number of prior chemotherapy regimens | |
| 0 | 19 (41) |
| 1 | 15 (33) |
| ≥2 | 12 (26) |
| CTC (Veridex) (n = 43) | |
| < 5 | 24 (56) |
| ≥5 | 19 (44) |
| Laboratory Values | Median (range) |
| PSA, ug/ml | 105.6 (2.4, 4340.5) |
| Hemoglobin | 12.1 (9.2, 15.6) |
| LDH | 243.0 (146, 791) |
| Alkaline Phosphatase | 99.5 (34, 1492) |
*
Brain, liver, and lung